Schwab, Richard B.

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial

Nanda, R., Liu, M. C., Yau, C., Shatsky, R., Pusztai, L., Wallace, A., Chien, A. J., Forero-Torres, A., Ellis, E., Han, H., et al. (2020) · JAMA Oncology

Breast Cancer Treatment StudiesCancer Treatment and Pharmacology

Cited by 710

Healthcare use and costs in adult cancer patients with anxiety and depression

Mausbach, B. T., Decastro, G., Schwab, R. B., Tiamson‐Kassab, M., & Irwin, S. A. (2020) · Depression and Anxiety

Cancer survivorship and careEconomic and Financial Impacts of Cancer

Cited by 95

On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients

Schwaederle, M., Daniels, G. A., Piccioni, D. E., Fanta, P. T., Schwab, R. B., Shimabukuro, K. A., Parker, B. A., & Kurzrock, R. (2015) · Molecular Cancer Therapeutics

Cancer Genomics and DiagnosticsGenomics and Rare Diseases

Cited by 90